The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

The following is a summary of “Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic ...

The addition of SGLT2i to RAASi was associated with lower hyperkalemia risk among patients with diabetes, heart failure, or CKD.

One new feature tracks a user's meals, with the help of photos, and the other tracks the user's glucose intake. There's no exact release date for these new features. The meals feature allows users ...

Home glucose meters can help lower your risk of complications from diabetes. Along with treatment, using a home monitor can help you identify the things that make your blood sugar increase or ...

Health Minister Krista Lynn Howell says the glucose monitoring pilot program won't be impacted by the province's move to scrap the sugar tax. (Peter Cowan/CBC) Days after Newfoundland and Labrador ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of cardiorenal events in people with type 2 diabetes at high cardiovascular risk or with chronic kidney disease. However, their effect ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo ...